| | |

Peter Staley’s vivid pharma profit dream$

Peter Staley
(before cheek implants)

What’s up lately with my old pal and former pretty boy, Peter Staley?  He’s been kind of quiet on his Pharma-subsidized blog until just recently.

Peter loves all things Pharmaceutical and that is no surprise, considering he apparently lives a pretty good life taking his cut from Pharma profits.  As he himself admits, he founded aidsmed.com so he could get off of his low paying disability income.  The extent of his sell out is apparent to anyone looking at all the drug ads plastered above his mug on his blog.

Still, his latest post is pretty gauche, even for him.  Peter all but begs Gilead, manufacturer of the top selling AIDS drug Atripla, to share some of their ever increasing profits with groups like his.  “I certainly hope they’re giving back to affected communities — generously and often,” Peter writes.

No doubt due to his earlier career as a bond trader in the high finance world of Wall Street, Peter periodically blogs about the potential for his an investor’s pharmaceutical stock portfolio, in this case noting that Gilead’s fourth quarter profits rose a whopping 43%.

Peter, after facial implants and still under the influence of Pharma ads

Using his warped sense of humor (?), Peter bases his post’s headline  on one of the disturbing effects of Atripla:  sleep disruption and disturbing dreams.  While it is too soon to know about all the possible consequences of long term use of Atripla, some of the already reported effects include:

  • Changes in body fat (hence the need for cheek and butt implants)
  • Impaired concentration, confusion and abnormal thinking
  • Mood swings including anxiety, agitation, depression, paranoia (feeling very anxious or nervous) and euphoria (feeling very happy)
  • Sleep disturbance including insomnia, drowsiness, vivid dreaming and nightmares.
  • Diarrhea
  • Dizziness
  • Drowsiness
  • Headache
  • Trouble concentrating
  • Trouble sleeping
  • Psychiatric symptoms
  • Nervous system symptoms
  • Rash

You can also read some about individuals’ personal experiences with Atripla here.

Peter would no doubt like for me to think he is still fighting for sick people and holding BigPharma’s feet to the fire, but posts like these make me think he’s really just turning up the heat on his electric bed warmer on a cold winter night.

As we used to chant together in ACT UP, Peter:  “Shame”.

 

(Note: I wrote this draft in January, 2010, but never published it for some reason. Since then, Peter’s original blog post—indeed many of his archived posts—has been made inaccessible, but can still be found on the Wayback Machine here. I am post-dating this post, which is actually being published December 5, 2013.)

Wait... there's more!

  • 97

    97. That’s my latest CD4+ count, less than half the count from six weeks ago.

    That’s it. I have tried as many alternative treatments as I can think of to reverse the decline. I will be starting my third round of pharmaceutical ARVs as soon as I can get a prescription and fill it.

    This decision has been a long time coming, and in hindsight, I probably should have restarted a few months ago. There’s nothing magical about 97, or being below 100, but it’s as good a breaking point as any. I’ve long argued that there are two things to keep in mind about CD4 counts: one is the long-term trend; the other is single- or low double-digit counts.

  • Reduce AIDS drug toxicity and side effects

    I embarked on my third course of ARVs since 1998. For ten of the sixteen years I have been HIV-positive, I was able to manage well enough without ARVs and I continue to believe there is no reason for otherwise healthy HIV-positive—let alone negative—gay men to take these drugs. To those who want to wave a recent study about the benefits of early intervention in my face, I would ask them why they put so much faith in a science that has utterly failed us to date.

  • Retreat and Adventure — Midwest Men’s Festival

    When I received my HIV diagnosis in 1998, I withdrew from my community of gay men. I “went to ground”, thinking that isolation was the only safe place to avoid being criticized for seroconverting at such a late date, when we were all supposed to know better.

    This past week has been yet another bifurcation point in my life. I returned to a community I have known about, if not been a steady part of, for more than 30 years. A community of men whom I could touch and hug. Men whose tears might wet my face and whose body heat and life forces I could feel in ways that can only happen in person. It really did feel like coming home.

  • The truth about Truvada: PrEP won’t stop AIDS

    I’m willing to grant that gay men are entitled to use PrEP… provided they have access to all the information they need to make an informed decision. Informed consent has been a hallmark of the HIV and AIDS research and prevention efforts for three decades, and that shouldn’t be waived for the campaign favoring PrEP.

    Gay men deserve to know that all the claims for Truvada reducing the risk of acquiring HIV-positivity  are based on trials—funded by Gilead—that emphasized the importance of using condoms…

Leave a Reply

Your email address will not be published. Required fields are marked *